Allergy testing for Cremophor in a patient with cervical cancer with infusion reactions to paclitaxel and docetaxel

BMJ Case Rep. 2022 Jun 24;15(6):e250960. doi: 10.1136/bcr-2022-250960.

Abstract

A woman in her 30s with cervical cancer underwent postoperative chemotherapy and showed allergic reactions to multiple taxanes. As the patient had infusion reactions to both paclitaxel and docetaxel, a prick test with Cremophor was conducted. In the absence of an allergic reaction to etoposide, we determined that the patient was allergic to pure taxane compounds. Among infusion reactions caused by taxanes, Cremophor allergy is reported in 3% of cases. Therefore, a prick test with Cremophor performed on a taxane infusion reaction will be useful in diagnosing allergy. In addition, allergy due to docetaxel may be managed by adequate premedication and continuous intravenous chlorpheniramine administration.

Keywords: Cervical cancer; Chemotherapy; Gynecological cancer; Obstetrics, gynaecology and fertility; Unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Docetaxel / adverse effects
  • Female
  • Humans
  • Hypersensitivity*
  • Paclitaxel
  • Polyethylene Glycols
  • Taxoids / adverse effects
  • Uterine Cervical Neoplasms* / drug therapy

Substances

  • Taxoids
  • Docetaxel
  • cremophor
  • Polyethylene Glycols
  • Paclitaxel